Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

作者：Koks Carolien A; Garg Abhishek D; Ehrhardt Michael; Riva Matteo; Vandenberk Lien; Boon Louis; De Vleeschouwer Steven; Agostinis Patrizia; Graf Norbert; Van Gool Stefaan W^*

来源：International Journal of Cancer, 2015, 136(5): E313-E325.

DOI：10.1002/ijc.29202

• glioma
• Newcastle disease virus
• immunogenic cell death
• antitumor immunity
• necroptosis

The oncolytic features of several naturally oncolytic viruses have been shown on Glioblastoma Multiforme cell lines and in xenotransplant models. However, orthotopic glioma studies in immunocompetent animals are lacking. Here we investigated Newcastle disease virus (NDV) in the orthotopic, syngeneic murine GL261 model. Seven days after tumor induction, mice received NDV intratumorally. Treatment significantly prolonged median survival and 50% of animals showed long-term survival. We demonstrated immunogenic cell death (ICD) induction in GL261 cells after NDV infection, comprising calreticulin surface exposure, release of HMGB1 and increased PMEL17 cancer antigen expression. Uniquely, we found absence of secreted ATP. NDV-induced ICD occurred independently of caspase signaling and was blocked by Necrostatin-1, suggesting the contribution of necroptosis. Autophagy induction following NDV infection of GL261 cells was demonstrated as well. In vivo, elevated infiltration of IFN-(+) T cells was observed in NDV-treated tumors, along with reduced accumulation of myeloid derived suppressor cells. The importance of a functional adaptive immune system in this paradigm was demonstrated in immunodeficient Rag2(-/-) mice and in CD8(+) T cell depleted animals, where NDV slightly prolonged survival, but failed to induce long-term cure. Secondary tumor induction with GL261 cells or LLC cells in mice surviving long-term after NDV treatment, demonstrated the induction of a long-term, tumor-specific immunological memory response by ND virotherapy. For the first time, we describe the therapeutic activity of NDV against GL261 tumors, evidenced in an orthotopic mouse model. The therapeutic effect relies on the induction of ICD in the tumor cells, which primes adaptive antitumor immunity.
What's new? Glioblastoma multiforme has a particularly grim prognosis. One potential treatment is oncolytic virotherapy (OVT), which relies on viruses that specifically infect and lyse tumor cells. In this study, the authors found that mice whose gliomas were injected with Newcastle-disease virus (NDV) survived significantly longer than controls. Many researchers have assumed that, in order for OVT to work, the immune system must be suppressed. Here, however, NDV actually stimulated immunogenic cell death (ICD) and necroptosis (rather than apoptosis). OVT may thus be a promising therapeutic approach in combination with therapies that stimulate the immune response.

• 出版日期2015-3-1